Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study

The Breelib™ nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 µg using Breelib™ caused significant improvements in invasively measured afterload and cardiac index but not echo...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Manuel J., Wan, Jun, Ghofrani, Hossein A., Seeger, Werner, Gall, Henning, Rieth, Andreas, Tello, Khodr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740066/
https://www.ncbi.nlm.nih.gov/pubmed/31588353
http://dx.doi.org/10.1177/2045894019875342
_version_ 1783451044655661056
author Richter, Manuel J.
Wan, Jun
Ghofrani, Hossein A.
Seeger, Werner
Gall, Henning
Rieth, Andreas
Tello, Khodr
author_facet Richter, Manuel J.
Wan, Jun
Ghofrani, Hossein A.
Seeger, Werner
Gall, Henning
Rieth, Andreas
Tello, Khodr
author_sort Richter, Manuel J.
collection PubMed
description The Breelib™ nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 µg using Breelib™ caused significant improvements in invasively measured afterload and cardiac index but not echocardiographic right ventricular strain during 30 min post-inhalation.
format Online
Article
Text
id pubmed-6740066
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-67400662019-10-03 Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study Richter, Manuel J. Wan, Jun Ghofrani, Hossein A. Seeger, Werner Gall, Henning Rieth, Andreas Tello, Khodr Pulm Circ Research Letter The Breelib™ nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 µg using Breelib™ caused significant improvements in invasively measured afterload and cardiac index but not echocardiographic right ventricular strain during 30 min post-inhalation. SAGE Publications 2019-09-11 /pmc/articles/PMC6740066/ /pubmed/31588353 http://dx.doi.org/10.1177/2045894019875342 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Letter
Richter, Manuel J.
Wan, Jun
Ghofrani, Hossein A.
Seeger, Werner
Gall, Henning
Rieth, Andreas
Tello, Khodr
Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
title Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
title_full Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
title_fullStr Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
title_full_unstemmed Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
title_short Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
title_sort acute response to rapid iloprost inhalation using the breelib™ nebulizer in pulmonary arterial hypertension: the breelib™ acute study
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740066/
https://www.ncbi.nlm.nih.gov/pubmed/31588353
http://dx.doi.org/10.1177/2045894019875342
work_keys_str_mv AT richtermanuelj acuteresponsetorapidiloprostinhalationusingthebreelibnebulizerinpulmonaryarterialhypertensionthebreelibacutestudy
AT wanjun acuteresponsetorapidiloprostinhalationusingthebreelibnebulizerinpulmonaryarterialhypertensionthebreelibacutestudy
AT ghofranihosseina acuteresponsetorapidiloprostinhalationusingthebreelibnebulizerinpulmonaryarterialhypertensionthebreelibacutestudy
AT seegerwerner acuteresponsetorapidiloprostinhalationusingthebreelibnebulizerinpulmonaryarterialhypertensionthebreelibacutestudy
AT gallhenning acuteresponsetorapidiloprostinhalationusingthebreelibnebulizerinpulmonaryarterialhypertensionthebreelibacutestudy
AT riethandreas acuteresponsetorapidiloprostinhalationusingthebreelibnebulizerinpulmonaryarterialhypertensionthebreelibacutestudy
AT tellokhodr acuteresponsetorapidiloprostinhalationusingthebreelibnebulizerinpulmonaryarterialhypertensionthebreelibacutestudy

Ejemplares similares